Foresite Capital Management V, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ALUMIS INC. | 0 | 5,896,995 | +5,896,995 | 0 | 129,910,800 | 47.94% | +129,910,800 |
| CG Oncology, Inc.(CGON) | 0 | 1,004,050 | +1,004,050 | 0 | 67,954,104 | 25.08% | +67,954,104 |
| Eikon Therapeutics, Inc. | 0 | 1,318,983 | +1,318,983 | 0 | 13,954,840 | 5.15% | +13,954,840 |
| Hims & Hers Health, Inc.(HIMS) | 0 | 738,151 | +738,151 | 0 | 15,324,015 | 5.65% | +15,324,015 |
| Pharvaris N.V. | 0 | 194,125 | +194,125 | 0 | 5,484,031 | 2.02% | +5,484,031 |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 265,000 | +265,000 | 0 | 4,107,500 | 1.52% | +4,107,500 |
| Disc Medicine, Inc.(IRON) | 0 | 374,069 | +374,069 | 0 | 23,917,972 | 8.83% | +23,917,972 |
| Maze Therapeutics, Inc.(MAZE) | 0 | 25,905 | +25,905 | 0 | 773,264 | 0.29% | +773,264 |
| Lyell Immunopharma, Inc. | 0 | 477,078 | +477,078 | 0 | 9,570,185 | 3.53% | +9,570,185 |
| Natera, Inc.(NTRA) | 0 | 0 | 0 | 0 | 0 | — | 0 |